Abstract
Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have